MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

IMAB I-MAB Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology
IMAB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For IMAB
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMAB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For IMAB
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

IMAB is expected to report earnings to rise 16.27% to -12 cents per share on November 29

I-MAB IMAB Stock Earnings Reports
Q3'23
Est.
$-0.13
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.22
Q1'24
Est.
$-0.22
Q4'23
Beat
by $0.36
The last earnings report on November 14 showed earnings per share of -10 cents, missing the estimate of -7 cents. With 82.28K shares outstanding, the current market capitalization sits at 83.01M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

IMAB and Stocks

Correlation & Price change

A.I.dvisor tells us that IMAB and CTMX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMAB and CTMX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
+2.88%
CTMX - IMAB
32%
Poorly correlated
-0.99%
ABOS - IMAB
31%
Poorly correlated
+3.16%
RPRX - IMAB
31%
Poorly correlated
-1.04%
BEAM - IMAB
30%
Poorly correlated
-4.33%
NTLA - IMAB
30%
Poorly correlated
-6.15%
More